IMC Chicago’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.94M Buy
34,100
+10,000
+41% +$877K ﹤0.01% 2654
2026
Q1
$2.18M Sell
24,100
-4,200
-15% -$385K ﹤0.01% 2485
2025
Q4
$2.54M Sell
28,300
-3,000
-10% -$284K ﹤0.01% 2227
2025
Q3
$3.08M Sell
31,300
-4,200
-12% -$416K ﹤0.01% 1945
2025
Q2
$3.24M Buy
+35,500
New +$3.43M ﹤0.01% 1686
2025
Q1
Sell
-26,000
Closed -$2.75M 3545
2024
Q4
$2.75M Buy
26,000
+10,800
+71% +$1.16M ﹤0.01% 1633
2024
Q3
$1.64M Buy
15,200
+3,000
+25% +$327K ﹤0.01% 1786
2024
Q2
$1.32M Buy
+12,200
New +$1.44M ﹤0.01% 1799

Other funds holding ZBH

IMC Chicago's ZBH Position: Q2 2026 in Review

IMC Chicago increased its Zimmer Biomet (ZBH) stake by 11% in Q2 2026, buying an estimated $59K and bringing the position to 6,787 shares worth $584K. The position accounts for ﹤0.01% of the portfolio, ranked #4462.

IMC Chicago first reported a position in ZBH in Q1 2026 and has held it in 2 quarters since. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • IMC Chicago held 6,787 shares of Zimmer Biomet worth $584K as of Q2 2026.
  • IMC Chicago bought 673 Zimmer Biomet shares in Q2 2026, an estimated $59K.
  • Zimmer Biomet made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4462 holding.
  • IMC Chicago first reported a position in Zimmer Biomet in Q1 2026 and has held it in 2 quarters since.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.